首页> 外文期刊>Journal of Pharmaceutical and Biomedical Analysis: An International Journal on All Drug-Related Topics in Pharmaceutical, Biomedical and Clinical Analysis >Plasma analysis of alpha-difluoromethylornithine using pre-column derivatization with naphthalene-2,3-dicarboxaldehyde/CN and multidimensional chromatography.
【24h】

Plasma analysis of alpha-difluoromethylornithine using pre-column derivatization with naphthalene-2,3-dicarboxaldehyde/CN and multidimensional chromatography.

机译:使用萘-2,3-二甲苯甲醛/ CN的柱前衍生化和多维色谱法对α-二氟甲基鸟氨酸进行血浆分析。

获取原文
获取原文并翻译 | 示例
           

摘要

A procedure for the plasma analysis of alpha-difluoromethylornithine (DFMO) has been developed that utilizes pre-column derivatization with naphthalene-2,3-dicarboxaldehyde/cyanide (NDA/CN) in pH 9.2 borate buffer. Selective derivatization of delta-amine of DFMO followed by quenching of the reaction results in the formation of a cyanobenz [f] isoindole (CBI) derivative that is stable for 24 h. Plasma was prepared for derivatization by a single step procedure which resulted in an ultrafiltrate compatible with derivatization and analysis. The DFMO derivative (CBI-DFMO) was separated from plasma interferences by multidimensional chromatography with an analysis time of 28 min. The response for DFMO in plasma was linear over the range of 2.1 x 10(-8) 2.1 x 10(-6) M after derivatization. This procedure encompasses a useful linear range and offers the advantages of minimal sample preparation and production of a stable fluorophor.
机译:已经开发出一种血浆α-二氟甲基鸟氨酸(DFMO)的分析方法,该方法利用在pH 9.2硼酸盐缓冲液中的萘-2,3-二甲醛/氰化物(NDA / CN)进行柱前衍生。 DFMO的δ-胺选择性衍生化,然后淬灭反应,形成了稳定24小时的氰基苯并[f]异吲哚(CBI)衍生物。通过一步步骤制备血浆以进行衍生化,从而产生与衍生化和分析兼容的超滤液。 DFMO衍生物(CBI-DFMO)通过多维色谱从血浆干扰物中分离出来,分析时间为28分钟。衍生后,血浆中DFMO的响应在2.1 x 10(-8)2.1 x 10(-6)M的范围内呈线性。该程序涵盖了有用的线性范围,并提供了最少的样品制备和稳定的荧光团生产的优势。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号